[Jaundice caused by niflumic acid (Inflaryl)].
D000814:Aniline Compounds / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000276:immunology; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D008099:Liver / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000009:adverse effects* / Q000627:therapeutic use
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids
Icterus door nifluminezuur (Inflaryl)